News

FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
Nature1d
COVID vaccine works faster with both doses in the same arm
Receiving a COVID-19 booster vaccine in the same arm as the first vaccine dose leads to a faster, more effective immune ...
FDA may ask Novavax to conduct additional trials of its Covid-19 vaccine to receive full approval
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
FDA Asks Vaccine Maker to Complete New Clinical Trial for Delayed Covid-19 Shot
A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...
Novavax shares soar after FDA request raises hope for COVID vaccine approval
Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full ...
FDA chief says they're looking at whether to approve COVID shots for next winter
The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.
BNT162b2 vaccine not only targets COVID-19 virus, but may also help reduce and control innate inflammation
Trinity College Dublin researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended ...
Vaccines for the flu and COVID can alter the menstrual cycle —and more
Vaccines for the flu and COVID-19 can alter the menstrual cycle, but the impact is temporary and there is no reason for vaccine hesitancy, while breast cancer deaths among women ages 20 to 49 ...
As FDA delays Novavax' COVID vaccine approval, patients fight back
CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA ...
Billions Spent, Billions Saved: The True Cost of the COVID Vaccine
When COVID-19 first emerged, the U.S., under President Donald Trump, made an urgent bet on vaccines — and it paid off ...
The Grand Junction Daily Sentinel4d
Novavax COVID Vaccine Moves Closer to Full FDA Approval
The vaccine is the only protein-based COVID shot still in use in the U.S. This approval would allow the vaccine to stay on ...